Your browser doesn't support javascript.
loading
Retraction notice to "miR-539 enhances chemosensitivity to cisplatin in non-small cell lung cancer by targeting DCLK1" [Biomed. Pharmacother. 106 (2018) 1072-1081].
Deng, Huixing; Geng, Qianqian; Ji, Ting; Yang, Aimin.
Afiliação
  • Deng H; Department of Nuclear Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
  • Geng Q; Department of Nuclear Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
  • Ji T; Department of Nuclear Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
  • Yang A; Department of Nuclear Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China. Electronic address: aimin_y@163.com.
Biomed Pharmacother ; 162: 114720, 2023 06.
Article em En | MEDLINE | ID: mdl-37087344

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Biomed Pharmacother Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Biomed Pharmacother Ano de publicação: 2023 Tipo de documento: Article